Recordati to keep OTC following CVC buyout
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Recordati insists that OTC will remain a “core” part of its business following the sale of a majority stake in the company to a consortium of private-equity funds led by CVC.